Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease-Reference-Cited by-同舟云学术

Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease

Published:2017-04-25 Issue:1 Volume:178 Page:130-136
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Sinakos Emmanouil¹^ORCID,Kountouras Dimitrios²³,Koskinas John⁴,Zachou Kalliopi⁵,Karatapanis Stylianos⁶,Triantos Christos⁷,Vassiliadis Themistoklis⁸,Goulis Ioannis¹,Kourakli Alexandra⁹,Vlachaki Efthymia¹⁰,Toli Barbara³,Tampaki Maria⁴,Arvaniti Pinelopi⁵,Tsiaoussis Georgios⁷,Bellou Aristea⁸,Kattamis Antonis¹¹,Maragkos Konstantinos¹²,Petropoulou Foteini¹³,Dalekos George N.⁴,Akriviadis Evangelos¹,Papatheodoridis George V.²

Affiliation:

1. 4th Medical Department; Aristotle University of Thessaloniki; Hippokratio Hospital; Thessaloniki Greece

2. Department of Gastroenterology; National and Kapodistrian University of Athens; Laiko General Hospital; Athens Greece

3. Mitera Hospital; Athens Greece

4. 2nd Medical Department; Hippokratio Hospital; University of Athens; Athens Greece

5. Department of Medicine and Research Laboratory of Internal Medicine; Medical School; University of Thessaly; Larissa Greece

6. Department of Internal Medicine; Hospital of Rhodes; Rhodes Greece

7. Department of Gastroenterology; University Hospital of Patras; Patras Greece

8. 3rd Medical Department; Papageorgiou Hospital; Aristotle University of Thessaloniki; Thessaloniki Greece

9. Thalassaemia Unit; Hospital of Patras; Patras Greece

10. Thalassaemia Unit; Hippokratio Hospital; Aristotle University of Thessaloniki; Thessaloniki Greece

11. Agia Sofia Children Hospital; University of Athens; Athens Greece

12. Thalassaemia Unit; Hippokratio Hospital; Athens Greece

13. Thalassaemia Unit; General Hospital; Athens Greece

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14640/fullpdf

Reference27 articles.

1. AASLD-IDSA 2016 Recommendations for testing, managing, and treating hepatitis C. American Association for the study of Liver Diseases - Infectious Diseases Society of America http://hcvguidelines.org/sites/default/files/HCV-Guidance_October_2016_a.pdf

2. Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis;Alavian;Journal of Viral Hepatitis,2010

3. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation;Angelucci;Blood,2002

4. Sofosbuvir and ledipasvir in attainment of SVR12 in sickle cell disease (SCD) sub-population with chronic hepatitis C (CHC). A single center prospective open label clinical pilot study - SLASH C Trial;Basu;Hepatology,2015

5. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C;Marco;Haematologica,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease;World Journal of Hepatology;2024-05-27

2. Iron as a therapeutic target in chronic liver disease;World Journal of Gastroenterology;2023-01-28

3. Challenges of Hepatitis C Virus Treatment in Thalassemia;Blood - Updates on Hemodynamics and Thalassemia;2022-03-16

4. Hepatitis C virus: A critical approach to who really needs treatment;World Journal of Hepatology;2022-01-27

5. Safety and efficacy of direct-acting antiviral drugs in the treatment of chronic hepatitis C virus infection in patients with thalassemia: a prospective study;Egyptian Liver Journal;2021-06-25